Related Experiment Video
Updated: May 24, 2026

Exploring Adipose Tissue Structure by Methylsalicylate Clearing and 3D Imaging
Published on: August 19, 2020
Methylglyoxal causes structural and functional alterations in adipose tissue independently of obesity
P Matafome1, D Santos-Silva, J Crisóstomo
1Laboratory of Physiology - IBILI, Faculty of Medicine, University of Coimbra, Portugal.
Context:
Adipose tissue is one of the first organs to develop insulin resistance even with moderate BMI. However, the contribution of developing hyperglycaemia and concomitant methylglyoxal increment to tissue dysfunction during type 2 diabetes progression was not addressed before.
Methods:
Young and aged Wistar and Goto-Kakizaki rats (non-obese model of type 2 diabetes) and a group of MG-treated W rats were used to investigate the chronic effects of hyperglycaemia and ageing and specifically MG-induced mechanisms.
Results:
Diabetic and aged rats showed decreased adipose tissue irrigation and interstitial hypoxia. Hyperglycaemia of diabetic rats leaded to fibrosis and accumulation of PAS-positive components, exacerbated in aged animals, which also showed decreased hipoadiponectinemia, increased MCP-1 expression and macrophage infiltration to glycated fibrotic regions. MG leaded to increased free fatty acids, hipoadiponectinemia, decreased irrigation, hypoxia and macrophage recruitment for glycated fibrotic regions.
Conclusions:
MG contributes to dysfunction of adipose tissue during type 2 diabetes progression.
Related Concept Videos
Obesity
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Proteoglycans
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Type II Diabetes II: Pathophysiology
Hyperglycemia
